Correlation Between Mediantechn and TME Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mediantechn and TME Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mediantechn and TME Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mediantechn and TME Pharma NV, you can compare the effects of market volatilities on Mediantechn and TME Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mediantechn with a short position of TME Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mediantechn and TME Pharma.

Diversification Opportunities for Mediantechn and TME Pharma

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Mediantechn and TME is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Mediantechn and TME Pharma NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TME Pharma NV and Mediantechn is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mediantechn are associated (or correlated) with TME Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TME Pharma NV has no effect on the direction of Mediantechn i.e., Mediantechn and TME Pharma go up and down completely randomly.

Pair Corralation between Mediantechn and TME Pharma

Assuming the 90 days trading horizon Mediantechn is expected to under-perform the TME Pharma. In addition to that, Mediantechn is 1.04 times more volatile than TME Pharma NV. It trades about -0.14 of its total potential returns per unit of risk. TME Pharma NV is currently generating about -0.03 per unit of volatility. If you would invest  16.00  in TME Pharma NV on September 1, 2024 and sell it today you would lose (1.00) from holding TME Pharma NV or give up 6.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Mediantechn  vs.  TME Pharma NV

 Performance 
       Timeline  
Mediantechn 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mediantechn has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
TME Pharma NV 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in TME Pharma NV are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, TME Pharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Mediantechn and TME Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mediantechn and TME Pharma

The main advantage of trading using opposite Mediantechn and TME Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mediantechn position performs unexpectedly, TME Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TME Pharma will offset losses from the drop in TME Pharma's long position.
The idea behind Mediantechn and TME Pharma NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Correlations
Find global opportunities by holding instruments from different markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments